140 related articles for article (PubMed ID: 32152463)
1. Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoids.
Hernandez D; Palau L; Norsworthy K; Anders NM; Alonso S; Su M; Petkovich M; Chandraratna R; Rudek MA; Smith BD; Jones RJ; Ghiaur G
Leukemia; 2020 Nov; 34(11):3077-3081. PubMed ID: 32152463
[No Abstract] [Full Text] [Related]
2. Retinoic acid, CYP26, and drug resistance in the stem cell niche.
Alonso S; Jones RJ; Ghiaur G
Exp Hematol; 2017 Oct; 54():17-25. PubMed ID: 28754309
[TBL] [Abstract][Full Text] [Related]
3. Activation of RARα induces autophagy in SKBR3 breast cancer cells and depletion of key autophagy genes enhances ATRA toxicity.
Brigger D; Schläfli AM; Garattini E; Tschan MP
Cell Death Dis; 2015 Aug; 6(8):e1861. PubMed ID: 26313912
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
Wan H; Dawson MI; Hong WK; Lotan R
Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
[TBL] [Abstract][Full Text] [Related]
6. all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia.
Ozpolat B; Mehta K; Tari AM; Lopez-Berestein G
Am J Hematol; 2002 May; 70(1):39-47. PubMed ID: 11994980
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
[TBL] [Abstract][Full Text] [Related]
8. Human bone marrow niche chemoprotection mediated by cytochrome P450 enzymes.
Alonso S; Su M; Jones JW; Ganguly S; Kane MA; Jones RJ; Ghiaur G
Oncotarget; 2015 Jun; 6(17):14905-12. PubMed ID: 25915157
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line.
Holmes WF; Soprano DR; Soprano KJ
J Biol Chem; 2002 Nov; 277(47):45408-19. PubMed ID: 12237293
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid 4-hydroxylase-mediated catabolism of all-trans retinoic acid and the cell proliferation in head and neck squamous cell carcinoma.
Kim SY; Yoo SJ; Kwon HJ; Kim SH; Byun Y; Lee KS
Metabolism; 2002 Apr; 51(4):477-81. PubMed ID: 11912557
[TBL] [Abstract][Full Text] [Related]
11. The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases.
Mologni L; Ponzanelli I; Bresciani F; Sardiello G; Bergamaschi D; Gianní M; Reichert U; Rambaldi A; Terao M; Garattini E
Blood; 1999 Feb; 93(3):1045-61. PubMed ID: 9920855
[TBL] [Abstract][Full Text] [Related]
12. Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance.
Alonso S; Hernandez D; Chang YT; Gocke CB; McCray M; Varadhan R; Matsui WH; Jones RJ; Ghiaur G
J Clin Invest; 2016 Dec; 126(12):4460-4468. PubMed ID: 27775549
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment.
Connolly RM; Nguyen NK; Sukumar S
Clin Cancer Res; 2013 Apr; 19(7):1651-9. PubMed ID: 23322901
[TBL] [Abstract][Full Text] [Related]
14. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR.
Schug TT; Berry DC; Toshkov IA; Cheng L; Nikitin AY; Noy N
Proc Natl Acad Sci U S A; 2008 May; 105(21):7546-51. PubMed ID: 18495924
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid receptor antagonist BMS453 inhibits the growth of normal and malignant breast cells without activating RAR-dependent gene expression.
Yang L; Munoz-Medellin D; Kim HT; Ostrowski J; Reczek P; Brown PH
Breast Cancer Res Treat; 1999 Aug; 56(3):277-91. PubMed ID: 10573118
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids.
Wan H; Oridate N; Lotan D; Hong WK; Lotan R
Cancer Res; 1999 Jul; 59(14):3518-26. PubMed ID: 10416619
[TBL] [Abstract][Full Text] [Related]
17. BAG3 in Tumor Resistance to Therapy.
De Marco M; Turco MC; Marzullo L
Trends Cancer; 2020 Dec; 6(12):985-988. PubMed ID: 32718905
[TBL] [Abstract][Full Text] [Related]
18. Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells.
Chattopadhyay N; Butters RR; Brown EM
Brain Res Mol Brain Res; 2001 Feb; 87(1):100-8. PubMed ID: 11223164
[TBL] [Abstract][Full Text] [Related]
19. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
de Vos S; Dawson MI; Holden S; Le T; Wang A; Cho SK; Chen DL; Koeffler HP
Prostate; 1997 Jul; 32(2):115-21. PubMed ID: 9215399
[TBL] [Abstract][Full Text] [Related]
20. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid.
Tobita T; Takeshita A; Kitamura K; Ohnishi K; Yanagi M; Hiraoka A; Karasuno T; Takeuchi M; Miyawaki S; Ueda R; Naoe T; Ohno R
Blood; 1997 Aug; 90(3):967-73. PubMed ID: 9242525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]